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Nanomedicine is now being introduced as a recent trend in the field of medicine. It has been documented that
metal nanoparticles have antimicrobial effects for bacteria, fungi and viruses. Recent advances in technology has
revived the use of silver nanoparticles in the medical field; treatment, diagnosis, monitoring and control of disease.
It has been used since ancient times for treating wide range of illnesses. Bacterial cells adheres to surfaces and
develop structures known as biofilms. These structures are natural survival strategy of the bacteria to invade the
host. They are more tolerant to commonly used antimicrobial agents, thus being more difficult to be controlled.
This leads to increase in severity of infection. In this study, we have investigated the effect of silver nanoparticles in
the formation of biofilm in multidrug resistant strains of Pseudomonas aeruginosa. Observation showed that biofilm
formation occurred at bacterial concentration of 106 cfu/ml for the sensitive strain of P. aeruginosa while in the
resistant strain, the biofilm was evident at bacterial concentration of about 103 cfu/ml. The biofilm were then tested
against various concentrations of silver nanoparticles to determine the inhibitory effect of the silver nanoparticles. In
the sensitive strain, 20 μg/ml of silver nanoparticles inhibited the growth optimally at bacterial concentration of
104 cfu/ml with an inhibition rate of 67%. Similarly, silver nanoparticles inhibited the formation of biofilm in the
resistant strain at an optimal bacterial concentration of 105 cfu/ml with an inhibition rate of 56%. Thus, silver
nanoparticles could be used as a potential alternative therapy to reduce severity of disease due to P. aeruginosa
infections.
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Pseudomonas aeruginosa, a gram negative bacterium, is
an important opportunistic pathogen. It has been reported
to be resistant to commonly used empirical antibiotic
treatment and has been documented to be responsible to
high rates of morbidity and mortality [1]. P.aeruginosa is
the causative pathogen for several infections which in-
cludes urinary tract infection, septicaemia, osteomyelitis
and endocarditis. Thus, it poses new challenges as the
emergence of multidrug resistance strains is at alarming
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article, unless otherwise stated.Nanoparticles are defined as nanoscale particles with
novel and distinctive physicochemical properties [2].
Today, nanotechnology has been used in many different
applications such as in the medical field; imaging and
medical apparatus [3], sensors [4], fabrics, cosmetics,
health products, and water remediation technologies.
Silver based topical dressing has been widely used as a
treatment for infections in burns, open wounds and
chronic ulcers [5]. Recently, silver nanoparticles has
been used as a molecular tool and method for targeted
drug delivery [6]. Currently, nanoantibiotics is seeking
our attention as it could be used as an alternative the-
rapy. Numerous literatures has reported the use as silver
nanoparticles as an antimicrobial agent. This includes
the report by Kim Kuk et al. [7] who documented thetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Escherichia coli and Staphylococcus aureus [7]. There
are also other researchers who investigated the similar
effect in Bacillus megaterium, Staphylococcus aureus,
Escherichia coli, Proteus vulgaris and Shigella sonnei
[8,9]. However, very minimal work has been carried out
in multidrug resistant strains of P. aeruginosa.
Biofilms are bacterial communities that colonize and
are found embedded, in a self-produced exopolysaccha-
ride matrix. They attach to surfaces or living tissues [10].
Formation of biofilms allows organisms to survive and
thrive in hostile environment, disperse to form new
niches and gives them significant advantages in pro-
tection against environmental fluctuations such as hu-
midity, temperature, pH, the concentration of nutrients
and waste removal [11,12]. Biofilms has been a problem
in the medical field, especially in delaying the process of
wound healing. The presence of biofilm has been as-
sociated with various diseases, i.e.: endocarditis, otitis
media, chronic prostatitis, cystic fibrosis, periodontitis,
infections caused by medical devices and nosocomial in-
fections [13,14]. The sites of infections may be different
but the characteristics (mechanism for biofilm forma-
tion) of the causative agent may be similar regardless of
the genus. They evade host immune defenses and tole-
rate treatment with antibiotics. Briefly, formation of
biofilm begins with irreversible binding of planktonic
bacteria to any surfaces. The bacteria then forms a com-
munity which adheres, synthesizes extracellular matrix,
matures and disperses around the site. The stages of bio-
film development is showed in Figure 1.
The bacteria adheres to the site of infection which has
constituents such as electrolytes, water and organic ma-
terial. The constituents may serve as a source of nutrient
for the bacteria. At this stage there will also be plank-
tonic bacteria that is adsorbed to the surface reversibly
[16]. At this stage the bacteria is susceptible to anti-
biotics. The adherence of the bacteria is aided by the piliFigure 1 Development of biofilm [15].or flagella and constituents of the bacteria cell i.e. lipo-
polysaccharide and influenced by the physicochemical
properties of the surface. Once the bacteria adhered irre-
versibly, the bacterial cells colonize the site and divides. At
this point, there would be chemical signals being released.
These signals suggest formation of a microbial population
and there would phenotypic changes to the bacteria.
When the bacterial cells senses other surrounding cells in
a limited space, there would be secondary signals released
(quorum sensing), which leads to autoinduction in the
synthesis of extracellular matrix. The biofilm then matures
and develop into three-dimensional biofilm structures
[17]. The matrix allows the interconnection of immobi-
lized cells which serves as a digestive system and shuts
them off from external extracellular enzymes [18,19]. The
bottom layers of the biofilm cells are deprived from nutri-
ents and oxygen; hence to have a low metabolic activity
[20]. Therefore, these cells are more tolerant to commonly
used antimicrobial agents than planktonic cells and treat-
ing them becomes difficult [21]. The final stage of the
development is detachment. This stage may or may not
occur, depending on the environmental condition, nu-
trients, oxygenation, and other limitations. Cells which de-
tach from the surfaces disperse as liquid or aerosols.
From our previous study [22], we found that silver
nanoparticles has bactericidal effect on multidrug resist-
ant P.aeruginosa. Therefore, in this study we investigated
the effect of silver nanoparticles in the formation of bio-




Organisms that are resistant to three or more classes of
antibiotics are considered as multidrug resistant (MDR).
Table 1 shows strains 19, 26, 38, 43a and 47 are MDR
strains as they exhibit resistance against carbapenems,
cephalosporin, aminoglycosides and fluoroquinolone.
Table 1 Antibiotic susceptibility of P. aeruginosa strains
Antibiotic class
Strains Carb-apenem Cephalo-sporin Aminogly-coside Fluoro-quinolone
Antibiotics* IPM CFP CAZ GM CIP
ATCC 27853 29 30 33 21 34
1 29 22 28 21 28
3 12 25 28 21 24
6 34 28 33 23 32
11 30 28 30 21 32
19 28 0 0 0 0
26 0 10 0 9 0
38 0 9 0 8 0
43a 9 0 0 16 0
47 21 12 0 12 0
*Interpretation according to CLSI; R = resistant; I = intermediate; S = sensitive IPM: R < 14 mm, I:14–15 mm, S >16 mm; CFP: R < 16, I:16–20, S > 20; CAZ: R <15, I :
15–17, S > 17; GM: R <13, I : 13–14,S > 14; CIP: R < 16, I : 16–20, S > 20. Numerics in bold indicate resistant.
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Biofilm formation was investigated in vitro by monitoring
the binding of 0.1% crystal violet to the bacterial cells ad-
hered to a microtiter plate. The optical density value was
used as an index to observe the ability to form biofilm in
this organism. Figure 2 shows the formation of biofilm in
three strains of Pseudomonas aeruginosa; strain 6 (repre-
sentative susceptible strain), strain 19 (representative of a
multidrug resistant strain) and the ATCC 27853 (American
Type Culture collection) strain which was used for com-
parison. It is observed that the biofilm is formed at bac-
terial cells of concentration of 103 cfu/ml in both the
susceptible and multidrug resistant strain, which is indi-
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Figure 2 Biofilm formation in P. aeruginosa strains. Formation of biofilm
susceptible strain), strain 19 (representative of a multidrug resistant strain) a
was used for comparison. It is observed that the biofilm is formed at bacte
multidrug resistant strain, which is indicated by an elevated value of OD.Inhibition of biofilm formation by silver nanoparticles
Figure 3(a) and 3(b) shows the biofilm inhibition assay of
sample 6 (representative of susceptible strain) and sample
19 (representative of multidrug resistant strain). The re-
sults show that activity of silver nanoparticles is highest at
the concentration of 20 μg/ml, with an inhibition rate of
67% and optimal at bacterial concentration of 104 cfu/ml
(Figure 3(a)). In the multidrug resistant strain, the inhi-
bition rate of silver nanoparticles was highest at concen-
tration of 20 μg/ml with a bacterial concentration of 105
and 106 cfu/ml. It was also observed that there was no
inhibition at bacterial concentration of 108 cfu/ml for all
concentration of silver nanoparticles in the sensitive
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Figure 3 Activity of silver nanoparticles in P. aeruginosa sensitive strain. (a) Biofilm inhibition assay of sample 6 (representative of
susceptible strain). (b) Biofilm inhibition assay of sample 19 (representative of multidrug resistant strain).
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lead to different extents of biofilm inactivation by the
silver nanoparticles. This is evident in Figure 3(a) and
3(b). The penetration rate of the biofilm may also differ
between the sensitive and the multidrug resistant strain.
The inhibition effect of silver nanoparticles also reduced
with the increase in the bacterial cell number. Previousstudy has also documented that negatively charged silver
nanoparticles can be electrostatically repulsed from the
negatively charged surfaces of bacterial cells [23]. This
suggests that the uptake of the silver nanoparticles could
be remarkably reduced as the rate of biofilm formed in-
creased. The ability of silver nanoparticles to agglomerate
may also hinder the activity of silver nanoparticles. They
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extent of biofilm.
Conclusion
This study shows that silver nanoparticles inhibit the
formation of biofilm and strains with different anti-
microbial activities have also different extent of biofilm
formation. It has an effect against multidrug resistant
strains of Pseudomonas aeruginosa. In order to conclude
the mechanism of inhibition of silver nanoparticles in
biofilm formation, the mechanism of uptake should be
investigated in both the sensitive and multidrug resistant
strains.
Methods
Characterisation of silver (Ag) nanoparticles
Silver (Ag) nanoparticles were purchased from Sigma
Aldrich, Sdn Bhd, Malaysia. The nanoparticles used are
of sizes that ranged from 20–30 nm. An X-ray diffrac-
tion test was carried out on the silver flakes and powder;
the phases in Figure 4 show the existence of Ag only,
which confirms that the material was pure silver.
Bacterial strains and culture media
Ten clinical isolates of P. aeruginosa strains comprising of
five multidrug resistant (MDR) strains were used in the
study. Four strains that were susceptible to common em-
pirical antibiotics imipenem (IPM), ceftazidime (CAZ),
cefoperazone (CFP), gentamicin (GM) and ciprofloxacin











Figure 4 X-ray diffraction pattern for silver (Ag).heart infusion (BHI) and Muller Hinton (MH) agar were
used as culture media.
Antimicrobial susceptibility test
The method used was the agar disk diffusion method as
described in Clinical and Laboratory Institute [24]. Ap-
proximately 108 cfu/ml of bacterial colonies were lawned
onto MH agar plates. Antibiotic discs were placed onto
the agar plates. The plates were incubated overnight (18–
24 hr) at 37°C. The diameter of zone of inhibition around
the disc was observed and recorded. Experiments were
conducted in triplicates and average inhibitory zone dia-
meter with its standard deviation was determined.
Biofilm formation assay
The biofilm assay was carried in a 96-well-flat bottom tis-
sue culture plate (Greiner-bio One, German). Briefly, The
bacterial suspension was adjusted to be equivalent to 0.5
McFarland’s standard. A serial dilution was then prepared
from 108 cfu/ml till 10 cfu/ml. Each well of the microtiter
plate was filled with 150 ul of bacterial suspension. The
plate was incubated for 24 h at 37°C. After incubation, the
bacterial suspension of each well was gently removed. The
wells were washed three times with 0.2 mL of phos
phate buffer saline (PBS pH7.2) to remove free-floating
‘planktonic’ bacteria. Adherence of bacteria to the culture
plate were stained with crystal violet (0.1%, w/v). Excess
stain was rinsed off by washing with deionized water and
plates were kept for drying. After drying, 95% ethanol
was added to the wells and the optical densities (OD)
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The optical density value was considered as the formation
of biofilm on the surface of the culture plate. The experi-
ment was performed in triplicates.
Biofilm inhibition assay
The bacterial suspension was adjusted equivalent to 0.5
McFarland’s standard. A volume of 100 μl of bacterial sus-
pension was pipetted to each well of a microtiter plate.
The silver nanoparticles was diluted two-fold from a stock
concentration of 20 μg/ml. The lowest concentration used
was 0.06 μg/ml. The diluted silver nanoparticles were then
added to the suspension and incubated overnight at 37°C.
The method for the quantification of biofilm formation
was according to the method of [25]. Briefly, 100 μl sus-
pension of each well was transferred to fresh microtitre
plate. The plate was covered, sealed and incubated under
stationary conditions at 37°C. After 24 hours incubation,
the medium was discarded and thoroughly washed with
phosphate buffer saline (pH 7.2). A volume of 100 μl of
0.1% crystal violet was inoculated to each well and left for
30 min at ambient temperature of 25°C. Then, the stain
was discarded and the plate was thoroughly washed again.
The remaining stain was solubilized with 200 μl of 95%
ethanol. A volume of 125 μl of the ethanol solution was
then transferred into fresh microtitre plate for analysis at
590 nm.
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